Dilaudid 2 mg (Hydromorphone Hydrochloride)

Adult dose

The initial dose is 2 mg of hydromorphone hydrochloride orally every 4 ∼ 6 hours, depending on pain severity. Adjust the dose as appropriate according to pain severity, patient response, and body size. For more severe pain, administer 4 mg or more every 4 ∼ 6 hours. If tolerance develops or pain worsens, gradual dose increases may be necessary. If pain becomes severe or immediate intervention is required, initially use an appropriate amount of an injectable product for pain control. For patients with moderate (creatinine clearance 40 ～ 60 mL/min) or severe (creatinine clearance < 30 mL/min) renal impairment, use 1/4 ～ 1/2 of the usual hydromorphone hydrochloride dose (see section 10. Administration to patients with renal impairment under Precautions for Use). For patients with severe renal impairment, consider additionally increasing the dosing interval and monitor for opioid-related adverse reactions during maintenance treatment.

This medication is a narcotic analgesic that acts on the central nervous system, and using it in conjunction with other central nervous system depressants or alcohol carries a high risk of severe respiratory depression or coma. Therefore, such combinations should only be used in cases where absolutely necessary, at the lowest possible dosage for the shortest duration, and the patient's respiratory status and consciousness must be closely monitored. Patients with specific health conditions such as allergies to this medication, head injury, severe respiratory diseases, liver dysfunction, or pregnant women should not take this medication. Also, patients with genetic issues such as lactose intolerance should not take this medication. Elderly patients or those with decreased kidney function, or patients with respiratory diseases should exercise special caution when using this medication, and it is advisable to start with a low dosage to minimize the risk of side effects. This medication can lead to dependence, so patients' conditions should be closely observed during prolonged use, and sudden discontinuation may induce withdrawal symptoms, necessitating gradual dose reduction. During treatment, drowsiness, dizziness, or mental confusion may occur, and driving or operating hazardous machinery should be avoided. Pregnant or nursing women should not take this medication and should discontinue breastfeeding if they are nursing. In the case of overdose, severe respiratory depression, loss of consciousness, and heart problems may occur, requiring immediate emergency treatment. This medication can interact with various drugs; therefore, if taking other medications, it is essential to consult healthcare professionals. During the use of this medication, patients must strictly adhere to the prescribed dosage and administration instructions provided by healthcare providers, and report any unusual symptoms immediately.

Yawning, sneezing, tearing, sweating, nausea, vomiting, diarrhea, abdominal pain, pupillary dilation, headache, insomnia, anxiety, delirium, convulsions, tremors, pain in the muscles and joints throughout the body, respiratory distress, palpitations, dyspnea, slow breathing, irregular breathing, apnea, coma, confusion, disorientation, delirium, head injury, hypotension, shock, intestinal obstruction, toxic megacolon, sedation, drowsiness, mental confusion, physical and mental performance impairment, craving, fear, discomfort, psychological dependence, emotional changes, mental unrest, dizziness, weakness, excitation, muscle movement incoordination, muscle rigidity, paresthesia, muscle tremors, vision disorder, nystagmus, miosis, diplopia, transient hallucinations, flushing, euphoria, sweating, central sleep apnea syndrome, hypersensitivity to pain, thirst, constipation, biliary colic, anorexia, gastric cramps, taste changes, coldness, tachycardia, bradycardia, hypertension, circulatory disorders, peripheral circulatory collapse, cardiac arrest, orthostatic hypotension, fainting, ureteral spasms, spasms of the bladder sphincter, urinary retention, bronchospasm, laryngospasm, itching, urticaria, other skin rashes, convulsions, myoclonic seizures, respiratory depression, unconsciousness, skeletal muscle relaxation, cold skin, miosis, bradycardia, hypotension, apnea, circulatory collapse, cardiac arrest

This medication is sensitive to light and should be stored in a container that blocks light. It is advisable to store it at room temperature between 1 and 30 degrees Celsius.

Appearance

Orange round tablet

Package unit

100 tablets (10 tablets/PTP X 10)